Using IBD-REFER: A Substitute for Clinical Judgement?

Affiliations

¹ Assistant Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center.
² Pediatric Gastroenterology and Vice Chairman, Clinical Development and Research Affairs, Goryeb Children's Hospital/Atlantic Health, Professor of Pediatrics, Icahn School of Medicine at Mount Sinai.

Editorial

Jeffrey M Dueker et al. Crohns Colitis 360. 2020.

. 2020 Apr 24;2(2):otaa028.

doi: 10.1093/crocol/otaa028. eCollection 2020 Apr.

¹ Assistant Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center.
² Pediatric Gastroenterology and Vice Chairman, Clinical Development and Research Affairs, Goryeb Children's Hospital/Atlantic Health, Professor of Pediatrics, Icahn School of Medicine at Mount Sinai.

No abstract available

Comment in

1. Ng SC, Shi HY, Hamidi N, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. - PubMed
1. Berg DR, Colombel JF, Ungaro R. The role of early biologic therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1896–1905. - PMC - PubMed
1. Danese S, Fiorino G, Mary JY, et al. . Development of red flags index for early referral of adults with symptoms and signs suggestive of crohn’s disease: an IOIBD initiative. J Crohns Colitis. 2015;9:601–606. - PubMed
1. Teh SH, Nagorney DM, Stevens SR, et al. . Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261–1269. - PubMed